A Phase 1b/2, Open-label, Multicenter, Multi Arm Study of Evorpacept in Combination with Anti-cancer Therapies in Advanced / Metastatic Malignancies (ASPEN-09)
Clinical Trial Grant
Awarded By
ALX Oncology Inc.
Start Date
March 11, 2026
End Date
March 5, 2031
Awarded By
ALX Oncology Inc.
Start Date
March 11, 2026
End Date
March 5, 2031